MENU
+Compare
LGND
Stock ticker: NASDAQ
AS OF
Apr 1, 03:41 PM (EDT)
Price
$104.10
Change
-$1.04 (-0.99%)
Capitalization
2.07B

LGND Ligand Pharmaceuticals Forecast, Technical & Fundamental Analysis

Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine... Show more

Industry: #Biotechnology
LGND
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for LGND with price predictions
Mar 31, 2025

LGND sees its Stochastic Oscillator ascending out of oversold territory

On March 19, 2025, the Stochastic Oscillator for LGND moved out of oversold territory and this could be a bullish sign for the stock. Traders may want to buy the stock or buy call options. Tickeron's A.I.dvisor looked at 57 instances where the indicator left the oversold zone. In of the 57 cases the stock moved higher in the following days. This puts the odds of a move higher at over .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where LGND advanced for three days, in of 332 cases, the price rose further within the following month. The odds of a continued upward trend are .

LGND may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In of 214 cases where LGND Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on March 31, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on LGND as a result. In of 80 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for LGND turned negative on March 31, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 43 similar instances when the indicator turned negative. In of the 43 cases the stock turned lower in the days that followed. This puts the odds of success at .

LGND moved below its 50-day moving average on March 10, 2025 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for LGND crossed bearishly below the 50-day moving average on March 12, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 15 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where LGND declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. LGND’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock slightly better than average.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.434) is normal, around the industry mean (13.677). P/E Ratio (46.189) is within average values for comparable stocks, (64.969). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.870). Dividend Yield (0.000) settles around the average of (0.024) among similar stocks. P/S Ratio (11.494) is also within normal values, averaging (255.565).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

View a ticker or compare two or three
LGND
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

LGND is expected to report earnings to fall 3.94% to $1.22 per share on April 30

Ligand Pharmaceuticals LGND Stock Earnings Reports
Q1'25
Est.
$1.22
Q4'24
Beat
by $0.09
Q3'24
Beat
by $0.50
Q2'24
Beat
by $0.34
Q1'24
Beat
by $0.36
The last earnings report on February 27 showed earnings per share of $1.27, beating the estimate of $1.18. With 10.90K shares outstanding, the current market capitalization sits at 2.07B.
A.I.Advisor
published Dividends

LGND paid dividends on July 01, 2010

Ligand Pharmaceuticals LGND Stock Dividends
А quarterly dividend of $0.12 per share was paid with a record date of July 01, 2010, and an ex-dividend date of July 02, 2010. Read more...
A.I. Advisor
published General Information

General Information

a biotechnology company

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
555 Heritage Drive
Phone
+1 858 550-7500
Employees
58
Web
https://www.ligand.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MUBFX32.630.28
+0.87%
NYLI WMC Value Class I
BSPPX653.551.46
+0.22%
iShares S&P 500 Index Investor P
SMISX26.00N/A
N/A
Invesco Summit R6
JTKNX10.79N/A
N/A
JHancock Global Thematic Opps NAV
TRZYX17.97N/A
N/A
T. Rowe Price Latin America Z

LGND and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, LGND has been loosely correlated with AXON. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if LGND jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LGND
1D Price
Change %
LGND100%
-2.30%
AXON - LGND
49%
Loosely correlated
-1.68%
CRNX - LGND
41%
Loosely correlated
-3.43%
VCYT - LGND
41%
Loosely correlated
-1.56%
DNLI - LGND
41%
Loosely correlated
-8.02%
JANX - LGND
39%
Loosely correlated
-7.22%
More